An Autopsy Case of Reversible Cerebral Vasoconstriction Syndrome After a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination.

autopsy covid-19 epilepsy headache rcvs sars-cov-2 vaccination

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Apr 2024
Historique:
accepted: 29 04 2024
medline: 31 5 2024
pubmed: 31 5 2024
entrez: 31 5 2024
Statut: epublish

Résumé

A 73-year-old man with chronic obstructive pulmonary disease received the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine. The following day, the patient developed a headache, followed by a tonic-clonic seizure and decreased consciousness. Magnetic resonance imaging of the head revealed no signs of stroke but multiple vasoconstrictions. Despite antiepileptic therapy, the seizure persisted, and the patient died 40 hours after vaccination. An autopsy revealed multiple brain ischemia without any vascular lesions, suggesting reversible cerebral vasoconstriction syndrome (RCVS). In this case, RCVS was diagnosed radiographically and pathologically. Our case suggests that RCVS could be a cause of headache and epilepsy following the SARS-CoV-2 mRNA vaccination.

Identifiants

pubmed: 38817496
doi: 10.7759/cureus.59311
pmc: PMC11136619
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e59311

Informations de copyright

Copyright © 2024, Shimura et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Mai Shimura (M)

Department of Medical Oncology, National Cancer Center Hospital East, Chiba, JPN.
Department of Internal Medicine, Fujimi-Kogen Hospital, Fujimi-Kogen Medical Center, Nagano, JPN.

Hirohisa Fujikawa (H)

Center for General Medicine Education, School of Medicine, Keio University, Tokyo, JPN.
Department of Internal Medicine, Suwa Central Hospital, Nagano, JPN.

Masanobu Yazawa (M)

Department of Internal Medicine, Fujimi-Kogen Hospital, Fujimi-Kogen Medical Center, Nagano, JPN.

Yuki Matsumoto (Y)

Department of Pathology, Shinshu University School of Medicine, Nagano, JPN.

Mitsunori Yamada (M)

Department of Brain Disease Research, Shinshu University School of Medicine, Nagano, JPN.

Classifications MeSH